South Korea Pharmaceuticals

Mezzion Pharma Co Ltd (140410)

Track

Track

Mezzion Pharma Co Ltd recorded seven buy transactions totaling 200.25 million KRW on October 20, 2026. Representative Director Bak Dong Hyeon executed all these acquisitions. Despite a 14.4% share price increase over the past quarter, the stock currently trades near its 52-week low. No recent earnings report data is available for context.
Ticker: 140410 Exchange: KOE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Bak Dong Hyeon (박 동 현) Representative Director (대표이사) Executive Director Large shareholder
Transaction date
Purchase
Price
384.18
Quantity 42,404 +3.9%
Value ₩4,993,211
Bak Dong Hyeon (박 동 현) Representative Director (대표이사) Executive Director Large shareholder
Transaction date
Purchase
Price
478.80
Quantity 96,019 -39.2%
Value ₩582,913
Bak Dong Hyeon (박 동 현) Representative Director (대표이사) Executive Director Large shareholder
Transaction date
Purchase
Price
205.25
Quantity 37,431 -0.3%
Value ₩4,830,197
Bak Dong Hyeon (박 동 현) Representative Director (대표이사) Executive Director Large shareholder
Transaction date
Purchase
Price
55,700.00
Quantity 1,000 +0.0%
Value ₩100,000
Bak Dong Hyeon (박 동 현) Representative Director (대표이사) Executive Director Large shareholder
Transaction date
Purchase
Price
55,400.00
Quantity 1,000 +0.1%
Value ₩100,000
Bak Dong Hyeon (박 동 현) Representative Director (대표이사) Executive Director Large shareholder
Transaction date
Purchase
Price
55,300.00
Quantity 1,000 +0.0%
Value ₩100,000
Bak Dong Hyeon (박 동 현) Representative Director (대표이사) Executive Director Large shareholder
Transaction date
Purchase
Price
55,200.00
Quantity 1,000 +0.0%
Value ₩100,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-20 2026-10-20 B Purchase Bak Dong Hyeon (박 동 현)

Representative Director (대표이사)

Executive Director Large shareholder
42,404 +3.9%
384.18
₩4,993,211 		42,404 +3.9% 384.18 ₩4,993,211
2026-10-20 2026-10-20 B Purchase Bak Dong Hyeon (박 동 현)

Representative Director (대표이사)

Executive Director Large shareholder
96,019 -39.2%
478.80
₩582,913 		96,019 -39.2% 478.80 ₩582,913
2026-10-20 2026-10-20 B Purchase Bak Dong Hyeon (박 동 현)

Representative Director (대표이사)

Executive Director Large shareholder
37,431 -0.3%
205.25
₩4,830,197 		37,431 -0.3% 205.25 ₩4,830,197
2026-10-20 2026-10-20 B Purchase Bak Dong Hyeon (박 동 현)

Representative Director (대표이사)

Executive Director Large shareholder
1,000 +0.0%
55,700.00
₩100,000 		1,000 +0.0% 55,700.00 ₩100,000
2026-10-20 2026-10-20 B Purchase Bak Dong Hyeon (박 동 현)

Representative Director (대표이사)

Executive Director Large shareholder
1,000 +0.1%
55,400.00
₩100,000 		1,000 +0.1% 55,400.00 ₩100,000
2026-10-20 2026-10-20 B Purchase Bak Dong Hyeon (박 동 현)

Representative Director (대표이사)

Executive Director Large shareholder
1,000 +0.0%
55,300.00
₩100,000 		1,000 +0.0% 55,300.00 ₩100,000
2026-10-20 2026-10-20 B Purchase Bak Dong Hyeon (박 동 현)

Representative Director (대표이사)

Executive Director Large shareholder
1,000 +0.0%
55,200.00
₩100,000 		1,000 +0.0% 55,200.00 ₩100,000
Explore more

More insider trading research around Mezzion Pharma Co Ltd

More insider trades in South Korea
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in Asia-Pacific